Trial Profile
Multicenter, Randomized, Double-blind, Parallel-group Study of Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Crohn's disease
- Focus Registrational; Therapeutic Use
- Acronyms Crodex
- Sponsors EryDel
- 18 Sep 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 10 Mar 2012 This trial has been discontinued in Italy and recruiting in Spain.
- 28 Dec 2011 Actual patient number (51) added as reported by ClinicalTrials.gov.